Treatment of metastatic breast cancer with paclitaxel and doxorubicin.

Dombernowsky, P; Gehl, J; Boesgaard, M; Jensen, T P; Jensen, B W; Ejlertsen, B

Dombernowsky, P; Gehl, J; Boesgaard, M; Jensen, T P; Jensen, B W; Ejlertsen, B.

Affiliation

Dombernowsky P; Department of Oncology, Herlev Hospital, University of Copenhagen, Denmark.

Semin Oncol ; 22(6 Suppl 15): 13-7, 1995 Dec.

Article in En | MEDLINE | ID: mdl-8643964

Subject(s)

Antibiotics, Antineoplastic/administration & dosage; Antineoplastic Agents, Phytogenic/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Doxorubicin/administration & dosage; Paclitaxel/administration & dosage; Antibiotics, Antineoplastic/adverse effects; Antineoplastic Agents, Phytogenic/adverse effects; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Doxorubicin/adverse effects; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Neoplasm Metastasis; Paclitaxel/adverse effects; Remission Induction

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Paclitaxel / Antibiotics, Antineoplastic / Antineoplastic Agents, Phytogenic Limits: Female / Humans Language: En Journal: Semin Oncol Year: 1995 Document type: Article Affiliation country: Denmark

Search on Google

Add to My VHL

XML

PubMed Links